Posted Nov. 23, 2009 at 1:48 p.m.
Salix
Salix Pharmaceuticals raises $128 million through stock offering
Post a comment
Print this blog postE-mail blog post
Share
Salix
On The Web
Site Search
Get the latest news alerts: Follow LTW at Twitter.
Local Tech Wire
RALEIGH, N.C. – Salix Pharmaceuticals (Nasdaq: SLXP) raised $128.2 million after expenses through a stock offering, the company said Monday.
Salix, which develops and sells gastrointestinal drugs, sold 5.5 million shares at $21 each.
Jefferies & Company, which handled the offering, also purchased 825,000 shares as part of its over-allotment option.
Salix shares traded Monday afternoon at $23.35.
“Salix intends to use the net proceeds from the offering for business development activities and other general corporate purposes,” the company said in a statement.
Featured
E-mail Preferences
The Skinny
- Who won 'Social Bowl'? Super Bowl ads paying fans to play
- RTP broadband firm Overture, minus two top execs, launches new look
- Will RTP-based ChannelAdvisor go public? They're thinking
- What brands are winning Super Bowl hype? Two Durham firms to find out
- In Super Bowl of social media, Patriots win, Triangle firm says
- Big job cuts coming at IBM? Don't be surprised
- Erskine Bowles is among those who can cash in big time on Facebook IPO
- Ignore Facebook hype - Check out 'risk factors,' too
- Facebook vs. Google IPO: Which deal ranks better?
- Triangle StartUp Factory says business already booming